The most common cancer, lung cancer, causes deaths worldwide. Most lung cancer patients have non-small cell lung carcinomas (NSCLCs) with a poor prognosis. The chemotherapies frequently cause resistance therefore search for new effective drugs for NSCLC patients is an urgent and essential issue. Deaminated thyroxine, tetraiodothyroacetic acid (tetrac), and its nano-analogue (NDAT) exhibit antiproliferative properties in several types of cancers. On the other hand, the most abundant secondary metabolite in the sponge Hippospongia sp., heteronemin, shows effective cytotoxic activity against different types of cancer cells. In the current study, we investigated the anticancer effects of heteronemin against two NSCLC cell lines, A549 and H1299 cells in vitro. Combined treatment with heteronemin and tetrac derivatives synergistically inhibited cancer cell growth and significantly modulated the ERK1/2 and STAT3 pathways in A549 cells but only ERK1/2 in H1299 cells. The combination treatments induce apoptosis via the caspases pathway in A549 cells but promote cell cycle arrest via CCND1 and PCNA inhibition in H1299 cells. In summary, these results suggest that combined treatment with heteronemin and tetrac derivatives could suppress signal transduction pathways essential for NSCLC cell growth. The synergetic effects can be used potentially as a therapeutic procedure for NSCLC patients.
Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1/2 inhibition.
C. Chung,Tung-Yung Huang,Hung-Ru Chu,R. De Luca,E. Candelotti,Chi-Hung Huang,Y. S. Yang,S. Incerpi,J. Pedersen,Chi-yu Lin,Haw-Ming Huang,Sheng Y. Lee,Zian Li,Chun A Changou,Wen-Shan Li,P. Davis,Hung-Yun Lin,J. Whang-peng,Kuan Wang
Published 2022 in Food and Chemical Toxicology
ABSTRACT
PUBLICATION RECORD
- Publication year
2022
- Venue
Food and Chemical Toxicology
- Publication date
2022-02-01
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-40 of 40 references · Page 1 of 1
CITED BY
Showing 1-13 of 13 citing papers · Page 1 of 1